Summary: About 30% of older adults whose brains show Alzheimer’s pathology never develop dementia symptoms. This study examines that phenomenon — called cognitive resilience — and explores how immature neurons in the aged human hippocampus may help preserve memory and cognition despite disease-related changes.
Researchers used donated brain tissue from the Netherlands Brain Bank to investigate whether adult neurogenesis — the birth of new neurons in adulthood — persists into old age and whether these immature cells behave differently in people who remain cognitively intact despite Alzheimer’s pathology. The findings suggest it is not simply the number of new cells that matters, but the way those cells respond to stress: in resilient brains these immature neurons activate survival and anti-inflammatory programs and appear to support surrounding tissue, potentially preserving network function.
Key Facts
- The 80-year-old nursery: Adult neurogenesis persists in the human hippocampus even in people over 80, appearing in brains from control donors, people with Alzheimer’s disease (AD), and those who carry AD pathology but remain cognitively resilient.
- Survival programs: Immature neurons in resilient individuals show gene-expression signatures linked to reduced cell death and lower inflammation, indicating intrinsic coping mechanisms that help these cells survive and function in a toxic environment.
- The “fertilizer” idea: Rather than simply replacing lost neurons in a one-for-one swap, these young cells may act as a supportive influence — a local source of trophic and regulatory signals that helps maintain the health and plasticity of nearby neural networks.
- A strategic shift in research: The study highlights a shift in neuroscience from focusing only on how brains fail during Alzheimer’s to studying how some brains succeed — the biological bases of cognitive resilience and resistance.
Source: KNAW
Why do some people lose memory while others stay mentally sharp despite the same Alzheimer’s changes in their brains?
This question motivates research into cognitive resilience, the capacity to preserve thinking and memory even when classic Alzheimer’s pathology is present. Understanding resilience could reveal new targets for therapies that aim to protect cognition, not only to slow pathology.
“Around 30 percent of older adults who develop Alzheimer’s pathology never experience symptoms,” says Evgenia Salta, last author on the study. “Why some people remain protected is a major unanswered question.”
Can the aging brain repair or protect itself?
One hypothesis is that resilient brains are better at repairing or supporting neural circuits as disease develops. This could include adding new neurons to vulnerable networks or activating cell-intrinsic programs that reduce damage. Adult neurogenesis — the production of new neurons in the adult hippocampus — has been well documented in animals but has been contentious in humans; this study provides molecular evidence that immature neurons persist in aged human hippocampus and that their transcriptional state correlates with cognitive outcome.
The researchers examined hippocampal tissue from control donors, people diagnosed with Alzheimer’s disease, and individuals with Alzheimer’s pathology who remained dementia-free. Because immature neurons are rare in aged human tissue, the team used high-resolution sampling of the hippocampal region where new neurons are most likely to appear and applied refined single-nucleus RNA sequencing plus new computational analyses to characterize these cells without over-relying on animal-based assumptions.
Finding immature neurons
The team identified populations of immature neurons across all donor groups, even at an average age above 80. These cells carry juvenile transcriptional profiles — gene-expression patterns typical of young neurons — but the critical distinction between groups was not abundance; it was cell behavior.
It’s not the number, it’s the behavior
In resilient individuals, immature neurons expressed programs linked to survival, stress resistance, and reduced inflammatory signaling. In contrast, immature neurons in symptomatic AD showed transcriptional signatures indicating compromised function. This suggests immature neurons in resilient brains may actively support the local environment — modulating inflammation, promoting repair, or sustaining network plasticity — rather than solely replacing lost neurons.
Salta cautions that while transcriptional data point to likely functions, direct demonstration of these roles requires further functional studies. Still, the results add an important piece to the resilience puzzle: cellular quality and state matter as much as cell numbers.
Toward new perspectives on Alzheimer’s
A broader question emerges: what determines the aging trajectory of the brain? At some point in later life the balance shifts for some people toward decline and for others toward maintained function. Identifying the molecular and cellular events that tip that balance could guide therapies aimed at promoting cognitive resilience. Future work will explore how immature neurons interact with other cell types in the hippocampus and whether their supportive programs can be enhanced therapeutically.
“Cognitive resilience is a promising avenue,” Salta says. “If we understand what protects these brains, we may develop new strategies to maintain cognition during aging.” For now, the study reinforces that the aging brain remains dynamic and that immature neurons in the hippocampus may play a meaningful role in preserving function.
Key Questions Answered:
A: It appears to be a matter of quality over quantity. Most aged brains still generate immature neurons, but in resilient individuals these cells show transcriptional programs that enhance survival and reduce inflammation, enabling them to better withstand Alzheimer’s-associated stress.
A: The data suggest the human hippocampus retains intrinsic repair and protective capacities. However, in symptomatic Alzheimer’s those mechanisms appear insufficient or suppressed. Translating these findings into therapies will require experiments that directly test how to activate protective programs in immature neurons.
A: Immature neurons in aged human tissue are rare and fragile. Detecting them required targeted sampling of the hippocampal niche, high-resolution sequencing, and analytical methods tailored to identify juvenile transcriptional states without relying strictly on animal models.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The full journal paper was reviewed.
- Additional context added by editorial staff.
About this Alzheimer’s disease and neurology research news
Author: Eline Feenstra
Source: KNAW
Contact: Eline Feenstra – KNAW
Image: The image is credited to Neuroscience News
Original Research: Closed access.
Title: Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer’s pathology and cognitive resilience
Journal: Cell Stem Cell
DOI: 10.1016/j.stem.2026.04.002
Abstract
Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer’s pathology and cognitive resilience
The presence and functional significance of immature neurons in the adult human brain — especially in the context of neurodegenerative disease — remain debated. While rodent models show active roles for adult-born immature neurons in hippocampal function and in models of Alzheimer’s disease, human data have been limited and lacked molecular detail. To address this, the authors performed single-nucleus RNA sequencing on hippocampal tissue from aged healthy donors, Alzheimer’s disease patients, and individuals with Alzheimer’s pathology who remained cognitively resilient. Using an integrated experimental and computational pipeline, they identified persistent immature neuronal populations across all groups with juvenile-like transcriptional profiles. These profiles are altered in Alzheimer’s disease and seem to correlate with resilience, suggesting that immature neurons may contribute to hippocampal homeostasis and cognitive protection in aging.